vktx stock forecast zacks
VTv Therapeutics saw a increase in short interest during the month of February. Evofem Biosciences Inc.
NASDAQEVFM issued its earnings results on Thursday March 3rd.
. Search for ticker symbols for Stocks Mutual Funds ETFs Indices and Futures on Yahoo. The biotechnology company reported 033 earnings per share for the quarter missing analysts consensus estimates of 023 by 010. As of February 28th there was short interest totaling 1930000 shares an increase of 191 from the February 13th total of 1620000 shares.
Viking Therapeutics Inc Vktx Stock Price Quote News Stock Analysis
Related
3 Strong Buy Biotech Stocks Trading Under 10
Viking Therapeutics Inc Vktx Stock Price Quote News Stock Analysis
How Much Upside Is Left In Viking Therapeutics Inc Vktx Wall Street Analysts Think 204 Nasdaq
Sensei Biotherapeutics Stock Forecast Price News Nasdaq Snse
Zacks Brokerages Anticipate Viking Therapeutics Inc Nasdaq Vktx Will Post Earnings Of 0 20 Per Share Marketbeat
Aiv Stock Predictions
How Much Upside Is Left In Viking Therapeutics Inc Vktx Wall Street Analysts Think 204 Nasdaq
Intercept Icpt Q4 Earnings Sales Beat Ocaliva In Focus Nasdaq
Nuvectis Pharma Stock Forecast Price News Nasdaq Nvct
Gemini Therapeutics Stock Forecast Price News Nasdaq Gmtx
Viking Therapeutics Inc Vktx Stock Price Quote News Stock Analysis
Https Seekingalpha Com Article 4213836 Labrador Iron Ore 34 Percent Upside Current Iron Ore Prices And Multiple Catalysts 2019 07 03t16 48 39 04 00 0 9 Yearly Https Seekingalpha Com Article 4213904 Pagseguro Fintech Disruptor Taking Swipes
Viking Therapeutics Inc Vktx Stock Price Quote News Stock Analysis
Viking Therapeutics Inc Vktx Now Trades Above Golden Cross Time To Buy Nasdaq
Coronavirus Stocks Companies Impacted By Covid 19
Viking Therapeutics Price Target Analyst Ratings Nasdaq Vktx
Viking Therapeutics Inc Vktx Stock Price Quote News Stock Analysis
Viking Therapeutics Inc Vktx Stock Price Quote News Stock Analysis
